263 related articles for article (PubMed ID: 34138399)
1. Impact of pre-admission antithrombotic therapy on disease severity and mortality in patients hospitalized for COVID-19.
Corrochano M; Acosta-Isaac R; Mojal S; Miqueleiz S; Rodriguez D; Quijada-Manuitt MÁ; Fraga E; Castillo-Ocaña M; Amaro-Hosey K; Albiol N; Soria JM; Antonijoan RM; Souto JC
J Thromb Thrombolysis; 2022 Jan; 53(1):96-102. PubMed ID: 34138399
[TBL] [Abstract][Full Text] [Related]
2. Combined anticoagulant and antiplatelet therapy is associated with an improved outcome in hospitalised patients with COVID-19: a propensity matched cohort study.
Matli K; Chamoun N; Fares A; Zibara V; Al-Osta S; Nasrallah R; Salameh P; Mokhbat J; Ghanem G
Open Heart; 2021 Oct; 8(2):. PubMed ID: 34611018
[TBL] [Abstract][Full Text] [Related]
3. Clinical impact of pre-admission antithrombotic therapy in hospitalized patients with COVID-19: A multicenter observational study.
Russo V; Di Maio M; Attena E; Silverio A; Scudiero F; Celentani D; Lodigiani C; Di Micco P
Pharmacol Res; 2020 Sep; 159():104965. PubMed ID: 32474087
[TBL] [Abstract][Full Text] [Related]
4. Previous Antithrombotic Therapy, Particularly Anticoagulant, Is Associated with Unfavorable Outcomes in Patients with Primary Spontaneous Intracerebral Hemorrhage Receiving Craniotomy: A Nationwide Population-Based Cohort Study.
Liu ZH; Chen NY; Tu PH; Yip PK; Wang YC; Chen CC; Chuang CC; Liu CH; Hsu PW; Lin YS
World Neurosurg; 2019 Aug; 128():e59-e73. PubMed ID: 30954751
[TBL] [Abstract][Full Text] [Related]
5. Association of Preceding Antithrombotic Treatment With Acute Ischemic Stroke Severity and In-Hospital Outcomes Among Patients With Atrial Fibrillation.
Xian Y; O'Brien EC; Liang L; Xu H; Schwamm LH; Fonarow GC; Bhatt DL; Smith EE; Olson DM; Maisch L; Hannah D; Lindholm B; Lytle BL; Pencina MJ; Hernandez AF; Peterson ED
JAMA; 2017 Mar; 317(10):1057-1067. PubMed ID: 28291892
[TBL] [Abstract][Full Text] [Related]
6. Mortality in relation to presence and type of oral antithrombotic agent among adult trauma patients: a single-center retrospective cohort study.
Yuval JB; Felix KJ; Demma J; Awissat H; Kedar A; Weiss DJ; Pikarsky AJ; Paltiel O; Hamdi-Levi I; Kalish Y; Bala M
Eur J Trauma Emerg Surg; 2022 Feb; 48(1):497-505. PubMed ID: 32627046
[TBL] [Abstract][Full Text] [Related]
7. Associations of antithrombotic agent use with clinical outcomes in critically ill patients with troponin I elevation in the absence of acute coronary syndrome.
Tsai CT; Lu YW; Chou RH; Tsai YL; Kuo MR; Guo JY; Lu CT; Kuo CS; Huang PH
PLoS One; 2020; 15(5):e0233178. PubMed ID: 32437395
[TBL] [Abstract][Full Text] [Related]
8. Antithrombotic Therapy Improves ICU Mortality of Septic Patients with Peripheral Vascular Disease.
Yuan S; Chen C; Xu F; Han D; Yang R; Zheng S; Qiao M; Huang X; Lyu J
Int J Clin Pract; 2022; 2022():1288535. PubMed ID: 35685503
[TBL] [Abstract][Full Text] [Related]
9. Relation of effective anticoagulation in patients with atrial fibrillation to stroke severity and survival (from the National Acute Stroke Israeli Survey [NASIS]).
Schwammenthal Y; Bornstein N; Schwammenthal E; Schwartz R; Goldbourt U; Tsabari R; Koton S; Grossman E; Tanne D
Am J Cardiol; 2010 Feb; 105(3):411-6. PubMed ID: 20102959
[TBL] [Abstract][Full Text] [Related]
10. Thromboembolic Rates Are Similar Between Intensive Care Unit and Nonintensive Care Unit Hospitalized Patients With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): A Retrospective Cohort Study.
Worth H; Helmlinger K; Raj R; Heidel E; Lands R
Clin Appl Thromb Hemost; 2021; 27():10760296211053315. PubMed ID: 34786969
[TBL] [Abstract][Full Text] [Related]
11. The Impact of Prior Antithrombotic use on Thromboembolic Events in Patients with Cardiovascular Disease and Severe COVID-19 Infection.
Bouchlarhem A; Boulouiz S; El Aidouni G; Bkiyar H; Bazid Z; Ismaili N; Housni B; El Ouafi N
Clin Appl Thromb Hemost; 2022; 28():10760296221141449. PubMed ID: 36514250
[TBL] [Abstract][Full Text] [Related]
12. Chronic anticoagulation is not associated with a reduced risk of acute kidney injury in hospitalised Covid-19 patients.
Parker K; Hamilton P; Hanumapura P; Castelino L; Murphy M; Challiner R; Thachil J; Ebah L
BMC Nephrol; 2021 Jun; 22(1):224. PubMed ID: 34134645
[TBL] [Abstract][Full Text] [Related]
13. Prestroke and Poststroke Antithrombotic Therapy in Patients With Atrial Fibrillation: Results From a Nationwide Cohort.
Gundlund A; Xian Y; Peterson ED; Butt JH; Gadsbøll K; Bjerring Olesen J; Køber L; Torp-Pedersen C; Gislason GH; Loldrup Fosbøl E
JAMA Netw Open; 2018 May; 1(1):e180171. PubMed ID: 30646049
[TBL] [Abstract][Full Text] [Related]
14. Anticoagulation Before Hospitalization Is a Potential Protective Factor for COVID-19: Insight From a French Multicenter Cohort Study.
Chocron R; Galand V; Cellier J; Gendron N; Pommier T; Bory O; Khider L; Trimaille A; Goudot G; Weizman O; Alsac JM; Geneste L; Schmeltz A; Panagides V; Philippe A; Marsou W; Ben Abdallah I; Deney A; El Batti S; Attou S; Juvin P; Delmotte T; Messas E; Pezel T; Planquette B; Duceau B; Gaussem P; Sutter W; Sanchez O; Waldman V; Diehl JL; Mirault T; Bonnet G; Cohen A; Smadja DM;
J Am Heart Assoc; 2021 Apr; 10(8):e018624. PubMed ID: 33550816
[TBL] [Abstract][Full Text] [Related]
15. Chronic anticoagulant treatment and risk of mortality in SARS-Cov2 patients: a large population-based study.
Montorfano M; Leoni O; Andreassi A; Ludergnani M; Moroni F; Ancona MB; Landoni G; Ciceri F; Zangrillo A
Minerva Med; 2023 Oct; 114(5):628-633. PubMed ID: 35191294
[TBL] [Abstract][Full Text] [Related]
16. Risk Factors Associated With Mortality Among Patients With COVID-19 in Intensive Care Units in Lombardy, Italy.
Grasselli G; Greco M; Zanella A; Albano G; Antonelli M; Bellani G; Bonanomi E; Cabrini L; Carlesso E; Castelli G; Cattaneo S; Cereda D; Colombo S; Coluccello A; Crescini G; Forastieri Molinari A; Foti G; Fumagalli R; Iotti GA; Langer T; Latronico N; Lorini FL; Mojoli F; Natalini G; Pessina CM; Ranieri VM; Rech R; Scudeller L; Rosano A; Storti E; Thompson BT; Tirani M; Villani PG; Pesenti A; Cecconi M;
JAMA Intern Med; 2020 Oct; 180(10):1345-1355. PubMed ID: 32667669
[TBL] [Abstract][Full Text] [Related]
17. Antithrombotic treatment and characteristics of elderly patients with non-valvular atrial fibrillation hospitalized at Internal Medicine departments. NONAVASC registry.
Gullón A; Suárez C; Díez-Manglano J; Formiga F; Cepeda JM; Pose A; Camafort M; Castiella J; Rovira E; Mostaza JM;
Med Clin (Barc); 2017 Mar; 148(5):204-210. PubMed ID: 27993408
[TBL] [Abstract][Full Text] [Related]
18. 'Real-world' antithrombotic treatment in atrial fibrillation: The EORP-AF pilot survey.
Lip GY; Laroche C; Dan GA; Santini M; Kalarus Z; Rasmussen LH; Ioachim PM; Tica O; Boriani G; Cimaglia P; Diemberger I; Hellum CF; Mortensen B; Maggioni AP
Am J Med; 2014 Jun; 127(6):519-29.e1. PubMed ID: 24486284
[TBL] [Abstract][Full Text] [Related]
19. Clinical outcomes and the impact of prior oral anticoagulant use in patients with coronavirus disease 2019 admitted to hospitals in the UK - a multicentre observational study.
Arachchillage DJ; Rajakaruna I; Odho Z; Crossette-Thambiah C; Nicolson PLR; Roberts LN; Allan C; Lewis S; Riat R; Mounter P; Lynch C; Langridge A; Oakes R; Aung N; Drebes A; Dutt T; Raheja P; Delaney A; Essex S; Lowe G; Sutton D; Lentaigne C; Sayar Z; Kilner M; Everington T; Shapiro S; Alikhan R; Szydlo R; Makris M; Laffan M
Br J Haematol; 2022 Jan; 196(1):79-94. PubMed ID: 34500500
[TBL] [Abstract][Full Text] [Related]
20. Deep vein thrombosis in hospitalized patients with coronavirus disease 2019.
Chang H; Rockman CB; Jacobowitz GR; Speranza G; Johnson WS; Horowitz JM; Garg K; Maldonado TS; Sadek M; Barfield ME
J Vasc Surg Venous Lymphat Disord; 2021 May; 9(3):597-604. PubMed ID: 33039545
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
